Protection of Marrow from Methotrexate Toxicity by Gene Transfer of Mutant Forms of Dihydrofolate Reductase into Hematopoietic Progenitor Cells
A potential clinical use of gene transfer technology would be to introduce via a retroviral vector, cDNAs encoding mutant forms of dihydrofolate reductase (DHFR) into hematopoietic progenitor cells, thus allowing high doses of methotrexate MTX to be safely administered. Mice bearing a chemotherapy sensitive breast cancer tumor, treated with high dose cyclophosphamide treatment and transplantated with bone marrow cells transfected with a mutant DHFR cDNA, tolerate high doses of MTX post transplant, leading to cure.
Additional studies are described that indicate that the use of a mutated nerve growth factor receptor (mNGFR) engineered into a vector also containing the S 31 mutant DHFR cDNA, allows identification of CD34+ hematopoietic progenitor cells that are expressing this surface protein.
KeywordsCodon Aldehyde Methotrexate Folate Cyclophosphamide
Unable to display preview. Download preview PDF.
- 3.Hryniuk W, Busch, H (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clinical Oncol 2: 1281–1288.Google Scholar
- 6.Zhao SC, Li MX, Banerjee D, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR (1994) Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase. Cancer Gene Therapy 1: 27PubMedGoogle Scholar
- 9.McLachlin JR, Eglitis MA, Ueda K, Kantoff PW, Pastan IH,Anderson WF, Gottesman MM (1990) Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. J Natl Cancer 82: 1260Google Scholar
- 11.Podda S, Ward M, Himelstein A, Richardson C, de la Flor-Weiss E, Smith L, Gottesman M, Pa-stan I, Bank A (1992) Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89: 9676Google Scholar
- 14:.Licht T,Aksentijevich I, Gottesman MM, Pastan I (1995) Efficient expression of functional human MDR1 into human and mouse hemapoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection. Br J Haematol 90: 876Google Scholar
- 16.Bertolini F, de Monte L, Corsini C, Lazzari L, Lauri E, Soligo D, Ward M, Bank A, Malavasi F (1994) Retrovirus-mediated transfer of the multidrug resistance gene into human hemopoietic progenitor cells. Br J Hematol 88: 318Google Scholar
- 18.Hanania EG, Fu S, Zu Z, Hegewisch-Becker S, Korbling M, Hester J, Druett A, Andreeff M, Mechetner E, Holzmayer T, Roninson IB, Giles RE, Berenson R, Heinfeld S, Deisseroth AB (1995) Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene. Gene Therapy 2 (4): 285–94PubMedGoogle Scholar
- 20.Cournoyer D, Letourneau S, Greenbaum M (1995) Hematopoietic chemoprotection from alkylating drugs by glutathione S-transferase gene transfer ( Meeting abstract ). Blood 86: A959Google Scholar
- 23.Harris LC, Marathi UK, Edwards CC, Houghton PJ, Srivastave DK,Vanin EF, Sorrentino BP, Brent TP (1995) Retroviral transfer of a bacterial alkyl transferase gene into murine bone marrow protects against chlorethylinitrosourea cytotoxicity. Clinical Cancer Research 1: 1359Google Scholar
- 24.Magni M, Shammah S, Schiro R, Bregni M, Siena S, DiNicola M, Dalla-Favera R, Gianni AM (1994) Gene therapy for drug-induced myelotoxicity: induction of cyclophosphamide resistance by aldehyde dehydrogenase-1 gene transfer ( Meeting Abstract ). Blood 84: A1414Google Scholar
- 25.Webb M, Sorrentino BP (1994) Retroviral transfer of the human cytosolic aldehyde dehydrogenase gene as a means to generate cellular cyclophosphamide resistance ( Meeting abstract ). Blood 84: A1415Google Scholar
- 27.Ercikan-Albali EA, Mineishi S, Tong Y, Nakahara S, Waltham MC, Banerjee D, Chen WC, Sadelain M, Bertino JR (1996) Active site-directed double mutants of dihydrofolate reductase. Cancer Res. 56: 4142–4145Google Scholar
- 28.Karlsson S (1991) Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 10: 2481–2492Google Scholar
- 31.Lewis WS, Cody V, Galitsky N, Luft JR, Pangborn W, Chunduru SK, Spencer HT, Appleman JR, Blakley RL (1995) Methotrexate-resistant variants fo human dihydrofolate reductase with substitutions of leucine 22. Kinetics, crystallography, and potential as selectable markers. J Biol Chem 270: 5057–5064Google Scholar
- 32.Morris JA, M`Ivor RS (1994) Saturation muta-genesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate resistance. Biochem Pharmacol 47: 1207–1212Google Scholar